Search

everythinglearnresearchcommunity

for

Search:↓

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

Heavy metals might contribute to hair loss in Telogen Effluvium.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

COVID-19 may cause hair loss by affecting hair follicles.

Minoxidil helps hair regrow faster in stress-related hair loss.

COVID-19 infection may cause hair loss.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

More atypical club hairs may indicate Telogen Effluvium.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Many COVID-19 patients, especially women, experienced hair loss, often linked to diabetes and lack of dietary supplements.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.